Literature DB >> 21839901

Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.

Julieta Galante1, Federico Augustovski, Lisandro Colantonio, Ariel Bardach, Joaquin Caporale, Sebastian Garcia Marti, Paul Kind.   

Abstract

OBJECTIVES: To estimate and compare EuroQol instrument (EQ-5D) health states' values for pneumococcal and human papillomavirus (HPV) diseases in Argentina, Chile, and the United Kingdom.
METHODS: Twelve vignettes were designed, pilot-tested, and administered to a convenience sample in a cross-sectional design to elicit descriptive EQ-5D state data. Country-specific EQ-5D time-trade-off-based weights were used to map these descriptive health states into local country preference weights. Descriptive analysis is reported and intercountry differences for each condition were compared using repeated measures analysis of variance.
RESULTS: Seventy-three subjects completed the survey. Pneumococcal disease-related health states mean values ranged from -0.331 (sepsis, Chile) to 0.727 (auditive sequelae, Argentina). HPV-related conditions ranged from 0.152 (cervical cancer, United Kingdom) to 0.848 (cervical intraepithelial neoplasia 1, Argentina). Chile had consistently the lowest mean values in pneumococcal states and in one HPV state, whereas those of the United Kingdom were the lowest in most HPV states. Argentina had the highest mean values in both diseases. Differences in country-specific values for each health state were statistically (P < 0.001) significant except for six health states in which differences between Chilean and United Kingdom weights were nonsignificant.
CONCLUSIONS: Utility values for most conditions differed statistically relevantly among analyzed countries, even though the same health states' descriptive set was valued for each. These results reflect the difference in social weights among different countries, which could be attributed to either different population values or valuation study methodologies. They stress the importance of using local preference weights for context-specific decision making.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21839901     DOI: 10.1016/j.jval.2011.05.007

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  13 in total

Review 1.  Utility scores for different health states related to depression: individual participant data analysis.

Authors:  Spyros Kolovos; Judith E Bosmans; Johanna M van Dongen; Birre van Esveld; Dorcas Magai; Annemieke van Straten; Christina van der Feltz-Cornelis; Kirsten M van Steenbergen-Weijenburg; Klaas M Huijbregts; Harm van Marwijk; Heleen Riper; Maurits W van Tulder
Journal:  Qual Life Res       Date:  2017-03-04       Impact factor: 4.147

Review 2.  Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.

Authors:  A Ó Céilleachair; J F O'Mahony; M O'Connor; J O'Leary; C Normand; C Martin; L Sharp
Journal:  Qual Life Res       Date:  2017-06-26       Impact factor: 4.147

3.  Elicitation of health state utilities associated with varying severities of flares in Systemic Lupus Erythematosus.

Authors:  C Pollard; S Hartz; S Liu Leage; M A Paget; J Cook; A Enstone
Journal:  Health Qual Life Outcomes       Date:  2015-05-28       Impact factor: 3.186

4.  A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample.

Authors:  Adelaide Mozzi; Michela Meregaglia; Carlo Lazzaro; Valentina Tornatore; Maurizio Belfiglio; Giovanni Fattore
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-13

Review 5.  Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.

Authors:  Louiza S Velentzis; Usha Salagame; Karen Canfell
Journal:  BMC Health Serv Res       Date:  2017-05-05       Impact factor: 2.655

6.  Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China.

Authors:  Liu Liu; Shunping Li; Min Wang; Gang Chen
Journal:  Patient Prefer Adherence       Date:  2017-06-23       Impact factor: 2.711

7.  Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions.

Authors:  Andres Pichon-Riviere; Federico Augustovski; Lisandro D Colantonio; Julieta Galante; Ariel Bardach; Joaquín E Caporale; Víctor Zárate; Ling Hsiang Chuang; Paul Kind
Journal:  Int J Health Policy Manag       Date:  2018-02-01

8.  Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium.

Authors:  Lander Willem; Adriaan Blommaert; Germaine Hanquet; Nancy Thiry; Joke Bilcke; Heidi Theeten; Jan Verhaegen; Herman Goossens; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2018-02-22       Impact factor: 3.452

9.  Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.

Authors:  Maíra Libertad Soligo Takemoto; Nilceia Lopes da Silva; Ana Carolina Padula Ribeiro-Pereira; Arthur Orlando Correa Schilithz; Cibele Suzuki
Journal:  Health Qual Life Outcomes       Date:  2015-08-06       Impact factor: 3.186

Review 10.  The impact of acute pneumococcal disease on health state utility values: a systematic review.

Authors:  Ryan O'Reilly; Sayako Yokoyama; Justin Boyle; Jeffrey C Kwong; Allison McGeer; Teresa To; Beate Sander
Journal:  Qual Life Res       Date:  2021-07-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.